Trio Healthcare: Chris Lane, Lloyd Pearce and Helen Jennings

Helen Jennings, Chris Lane and Lloyd Pearce - Trio
From left: Helen Jennings, Chris Lane and Lloyd Pearce

UK ostomy specialist Trio Healthcare has appointed Chris Lane as chief executive, to take charge of the company’s commercial and manufacturing operations prior to the global launch of its GeniiTM breathable silicone technology product range.

Lane has been Trio’s chief operating officer for the past two years and replaces Trio’s founder and former chief executive Lloyd Pearce, who becomes chief technology officer overseeing the company’s R&D team.

The business has also promoted Helen Jennings from finance director to chief financial officer. Jennings is a chartered accountant who previously worked for Deloitte and Crawford Healthcare. She assumes responsibilities from chief strategy officer Spencer Kerry, who oversaw the completion of a funding round of approximately £10 million from SWK Holdings in July. Kerry moves into the role of non-executive director.

Lane said: “It’s an incredibly exciting time to be part of the Trio team, and I’m grateful for the support of the business as I assume the role of CEO. Lloyd has played a pivotal role in Trio’s growth over the last 15 years, and it is a natural next step for him to assume the new role of CTO where he will continue to inspire our team to push boundaries in ostomy R&D. I’m delighted also to welcome Helen into her role as CFO. Her experience and diligence places the company in very good hands. 

“As we continue to grow rapidly and outpace our competition, our sights are firmly set on delivering our unique technology to a growing number of international markets. We have spent a number of months ensuring everything is in place for the successful launch of our new stoma bag range, in order to replicate the success it has already seen within the UK ostomy market. As ever, our commitment to improving the quality of life for those living with stomas by challenging the lack of innovation in the ostomy market is steadfast. We have the right people, R&D prowess and expertise in place to truly make a difference to ostomates across the globe, and I’m honoured to be leading this.”

Pearce added: “I wish Chris, Helen and Spencer all the best in their new roles, and am grateful for their support as I step into the CTO role. It has been, and continues to be, an enormous pleasure and source of great pride to see Trio grow, and the company is well-positioned for truly transformational growth under Chris’ astute guidance. I am excited to oversee our portfolio of world-beating silicone technologies and explore future innovation opportunities as CTO, continuing to work alongside the very best in the industry.” 

Join our mailing list

Stay up to date with all our events, awards and publications.

Information you provide us with will be kept private at all times, and will be used for communication and research purpose only.